Loading...

FOLD AMICUS THERAPEUTICS INC Company Mergers 8-K Filing

MCS

FLD

AMICUS THERAPEUTICS INC

(FOLD)

2025 8-K

Merger Approved

Financial Results Announced

Acquisition Update

Merger Announcement

Financial Results Update

Financial Statements

Financial Statements

Asset Acquisitions

Earnings Report

Earnings Update

Earnings Update

Earnings Update

Quantitative Data

Quantitative Data

Quantitative Data

Financial Performance Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Other Special Situation

Quantitative Data

Quantitative Data

Filing with Quantitative Data

Quantitative Data

Filing with Quantitative Data

Financial Performance Data

External Links:

On December 19, 2025, Amicus Therapeutics, Inc. agreed to merge with BioMarin Pharmaceutical Inc., with shareholders receiving $14.50 in cash for each share held. The merger is expected to close in the second quarter of 2026.

AI Assistant

AMICUS THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.